This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

JPMorgan Chase Redeems $9 Billion in Trust Preferreds (Update 1)

Updated with increased earnings estimates from UBS analyst Brennan Hawken, and with stock information for JPMorgan.

NEW YORK ( TheStreet) -- JPMorgan Chase (JPM - Get Report) announced late Monday that it would redeem $9 billion in trust preferred securities on July 12.

Because the new regulatory capital rules announced by the Federal Reserve exclude most trust preferred equity from Tier 1 capital, the regulatory changes qualify as a "Capital Treatment Event," allowing JPMorgan Chase to redeem the relatively high-yielding securities at par value, rather than at their premium market values. The following trust preferred issues will be redeemed:

  • JPMorgan Chase Capital XV, Series O, with a coupon of 5.875%, for $92.9 million.
  • JPMorgan Chase Capital XVII, Series Q, with a coupon of 5.850%, for $500 million.
  • JPMorgan Chase Capital XVIII, Series R, with a coupon of 6.950%, for $750 million.
  • JPMorgan Chase Capital XX, Series T, with a coupon of 6.550%, for $909.6 million.
  • JPMorgan Chase Capital XXII, Series V, with a coupon of 6.450%, for $913.8 million.
  • JPMorgan Chase Capital XXV, Series Y, with a coupon of 6.800%, for $1.5 billion.
  • JPMorgan Chase Capital XXVI; Series Z, fixed-to-floating-rate, for $1.8 billion.
  • JPMorgan Chase Capital XXVII, Series AA, with a coupon of 7.000%, for $1 billion.
  • JPMorgan Chase Capital XXVIII, Series BB, fixed-to-floating-rate, for $1.5 billion.

UBS analyst Brennan Hawken on Tuesday raised his 2012 earnings estimate for JPMorgan Chase to $4.70 a share from $4.65, and his 2013 EPS estimate to $5.55 from $5.45, "driven by the redemption of the TruPS."

Hawken maintained his "Buy," rating for the shares, with a price target of $46, and said the target "assumes JPM will trade at 1.3x our 4Q12 tangible book value estimate in 12 months (vs. 10-year avg. of 1.9x)," adding that "we believe the trading incident," announced on May 10, with hedge trading losses estimated at $2 billion, "will not permanently impair JPM's ability to generate mid-teens returns on tangible equity , and believe its current valuation of 1.0x TBV will prove a highly attractive entry point."

JPMorgan's shares closed at $32.82 Monday, for a flat year-to-date return, following a 20% decline during 2011.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

The shares trade for 0.9 times their reported March 31 tangible book value of $34.91, and for six times the consensus 2013 EPS estimate of $5.33, among analysts polled by Thomson Reuters. The consensus 2012 EPS estimate is $4.33.

Interested in more JPMorgan Chase? See TheStreet Ratings' report card for this stock.

RELATED STORIES:

-- Written by Philip van Doorn in Jupiter, Fla.

>Contact by Email.

Philip W. van Doorn is a member of TheStreet's banking and finance team, commenting on industry and regulatory trends. He previously served as the senior analyst for TheStreet.com Ratings, responsible for assigning financial strength ratings to banks and savings and loan institutions. Mr. van Doorn previously served as a loan operations officer at Riverside National Bank in Fort Pierce, Fla., and as a credit analyst at the Federal Home Loan Bank of New York, where he monitored banks in New York, New Jersey and Puerto Rico. Mr. van Doorn has additional experience in the mutual fund and computer software industries. He holds a bachelor of science in business administration from Long Island University.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
JPM $66.47 -0.27%
AAPL $132.54 0.88%
FB $80.54 0.07%
GOOG $540.11 -0.44%
TSLA $247.73 0.86%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs